How valuable are your customers in the brand value co-creation process? The development of a Customer Co-Creation Value (CCCV) scale.

Despite an increasing amount of research on co-creation of value, in general, research on brand value co-creation remains limited. Particularly, how much value customers contribute to the brand value co-creation process remains unclear. This research develops in a series of eight studies the Customer Co-Creation Value (CCCV) measurement scale that helps firms assess the value of customers in the brand value co-creation process. The findings reveal that CCCV is a multidimensional construct consisting of two higher-order factors and seven dimensions: customer-owned resources (including brand knowledge, brand skills, brand creativity, and brand connectedness) and customer motivation (comprising brand passion, brand trust, and brand commitment). Further, the CCCV scale reliably and validly gauges the value customers contribute to a firm's brand. The CCCV framework helps marketing managers understand how customers can contribute to a firm's brand value cocreation efforts and how much value customers contribute to a brand in the co-creation process

MOESM1 of Impact of transfusion on patients with sepsis admitted in intensive care unit: a systematic review and meta-analysis

Additional file 1: Search strategy, Boolean algorithms an definition used into the study

MOESM2 of Impact of transfusion on patients with sepsis admitted in intensive care unit: a systematic review and meta-analysis

Additional file 2: Additional Tables and Figures

Parvocellular expression of AVPmRNA, CRHmRNA and iNOS in control and septic shock patients and in sham, septic and septic ED rats.

<p>Abbreviations: AVP, Vasopressin; CRH, Corticotropin Releasing Hormone; mRNA, messenger RNA; iNOS, inducible nitric oxide synthase; ED, Early death.</p><p>Results are expressed as median (IQR).The index of labelling CRH and AVP <i>in-situ</i> hybridization and iNOS immunohistochemistry ranged from 0 to 3.</p><p>Comparison between the following animal groups:</p>a<p>Sham <i>versus</i> Sepsis,</p>b<p>Sepsis <i>versus</i> Septic Shock,</p>c<p>Sham <i>versus</i> Septic Shock.</p

Antehypophyseal expression of ACTH, CRHR1 and V1b receptor in control and septic shock patients and in sham, septic and septic ED rats.

<p>Abbreviations: ACTH, Adreno-Corticotropic Hormone; V1b, Vasopressin receptor 1b; CRHR1, Corticotropin Releasing Hormone receptor 1; ED, Early death.</p><p>Results are expressed as median (IQR). The index of labelling of ACTH, CRHR1 and V1b receptor immunohistochemistry ranged from 0 to 3.</p><p>Comparison between the following animal groups:</p>a<p>Sham <i>versus</i> Sepsis,</p>b<p>Sepsis <i>versus</i> Septic Shock,</p>c<p>Sham <i>versus</i> Septic Shock.</p

PVN of patients who died from non-septic causes (A–C–E) or septic shock (B–D–F).

<p>CRH mRNA (A–B) and AVP mRNA (C–D) labelling after <i>in situ</i> hybridization expression did not differ between the two groups. iNOS (E–F) expression after immunohistochemistry (ABC peroxidase/DAB) was higher in septic shock patients.</p

Ante-hypophysis of patients who died from non-septic causes (A–C–E) or septic shock (B–D–F).

<p>Labelling of CRHR1 (A–B) and V1b receptor (C–D) after immunohistochemistry (ABC peroxidase/DAB) did not vary among the two groups. ACTH (E–F) immunostaining (ABC peroxidase/DAB) was decreased in septic shock patients.</p

Antibodies.

<p>*H: human; R: rat.</p

Additional file 1 of Oropharyngeal and intestinal concentrations of opportunistic pathogens are independently associated with death of SARS-CoV-2 critically ill adults

Additional file 1: Table S1. Result of the initial 16S rDNA sequencing in rectal samples. Table S2. Per pathogen rectal and oropharyngeal culture positivity, time to first positivity and abundance at first positivity. Table S3. Adjusted impact of abundance of Enterococcus spp., S. aureus and Candida spp. in oropharynx and rectum on day 90 mortality. (one adjusted model for each). Table S4. Univariate analysis of day 90 mortality* comparing survivors versus descedents. Fig S1. Quantitative culturing on agar plates. CFU: colony-forming unit. Fig S2. Pie chart of the distribution of Enterococcus spp. and Candida spp. species obtained by culture of all the rectal swabs (A) and oropharyngeal (B) swabs. Fig S3. Dot plots of the intestinal Enterococcus spp. and Candida spp. with regards to intestinal richness (genus level), Shannon and inverse Simpson indices. The Pearson correlation test was used (with the intestinal concentrations being considered as continuous variables)